文件名称：行业动态
文件大小：40KB
文件格式：PDF
更新时间：2024-07-19 15:39:50
学术 论文
Industry Update Industry Update Market meltdown The end of the Gencell experiment? The bottom appears to be falling out of the market for gene therapy as many of the large players who have dominated the sector cut back. The announcement that Aventis Pharma, the biggest single investor in gene therapy over the last decade, intends to restructure its Gencell gene the- rapy division into a separate operat- ing company, marks a new low in the fortunes of the industry. Simul- taneousl